Rodin Therapeutics

View All

Pharma news
Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod

Novo Nordisk has announced to enter into a collaboration with Dicerna’s RNAi platform to focus on metabolic and liver-related diseases. The companies will be focusing to advance the treatment landscape of the diseases such as non-alcoholic steatohepatitis (NASH), Type 2 diabetes and obesity. Nordisk will be inv...

Find More